Burning Rock Biotech (BNR) Leases (2020 - 2025)
Historic Leases for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $4.5 million.
- Burning Rock Biotech's Leases fell 6795.76% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 6795.76%. This contributed to the annual value of $7.3 million for FY2024, which is 32121.39% up from last year.
- As of Q3 2025, Burning Rock Biotech's Leases stood at $4.5 million, which was down 6795.76% from $5.3 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Leases registered a high of $51.6 million during Q4 2021, and its lowest value of $1.7 million during Q4 2023.
- Over the past 5 years, Burning Rock Biotech's median Leases value was $7.3 million (recorded in 2024), while the average stood at $10.5 million.
- As far as peak fluctuations go, Burning Rock Biotech's Leases surged by 217745.92% in 2021, and later crashed by 8646.33% in 2022.
- Quarter analysis of 5 years shows Burning Rock Biotech's Leases stood at $51.6 million in 2021, then crashed by 86.46% to $7.0 million in 2022, then tumbled by 75.25% to $1.7 million in 2023, then soared by 321.21% to $7.3 million in 2024, then tumbled by 37.78% to $4.5 million in 2025.
- Its Leases was $4.5 million in Q3 2025, compared to $5.3 million in Q2 2025 and $6.0 million in Q1 2025.